Showing results (2071-2080 of 2,174) with videos related to

Sort By:
Pageof 218
The New England Journal of Medicine|June 6, 2008
Hypothermia therapy after traumatic brain injury in childrenJames S Hutchison, Roxanne E Ward, Jacques Lacroix, et al.
Health Security|April 24, 2020
Ebola Virus Disease Preparedness Assessment and Risk Mapping in Uganda, August-September 2018Carol Nanziri, Alex Riolexus Ario, Vivian Ntono, et al.
Ergonomics|September 8, 2024
A systems approach to managing the risk of healthcare acquired infection in an acute hospital setting supported by human factors ergonomics, data science, data governance and AIMarie E Ward, Una Geary, Rob Brennan, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
ProtPipe: A Multifunctional Data Analysis Pipeline for Proteomics and PeptidomicsZiyi Li, Cory A Weller, Syed Shah, et al.
Stem Cell Reports|July 14, 2023
A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cellsVukasin M Jovanovic, Claire Weber, Jaroslav Slamecka, et al.
Nature Neuroscience|August 11, 2022
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease statesNina M Dräger, Sydney M Sattler, Cindy Tzu-Ling Huang, et al.
The Journal of Experimental Medicine|August 27, 2014
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLDMichael E Ward, Alice Taubes, Robert Chen, et al.
Elife|December 28, 2022
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectorsJoseph M Replogle, Jessica L Bonnar, Angela N Pogson, et al.
Antiviral Therapy|May 4, 2005
Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroidsSarah E Ward, Mona R Loutfy, Lawrence M Blatt, et al.
The Lancet. Oncology|November 1, 2020
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji K Kumar, Simon J Harrison, Michele Cavo, et al.
Pageof 218